Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen). (Q46436860)
scientific article published on 15 December 2004
Language:
Current Data About Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
(P31) (Q13442814)
(P248)
(P698) 15829326
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/15829326

(P50) (Q12002891)
(P1545) 3
(P1932) Stein Kaasa
(P248)
(P698) 15829326
(P813) Friday, December 22, 2017

(P304) 251-261
(P248)
(P698) 15829326
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/15829326

(P433) 2
(P248)
(P698) 15829326
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/15829326

(P478) 48
(P248)
(P698) 15829326
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/15829326

(P577) Wednesday, December 15, 2004
(P248)
(P698) 15829326
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/15829326

(P921) (Q974135)
(P887)

(Q418817)
(P887)

(Q412415)
(P887)

(P1433) (Q641464)
(P248)
(P698) 15829326
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/15829326

(P1476) "Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen)." (language: en)
(P248)
(P698) 15829326
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/15829326

(P2093) Stein Sundstrøm
(P1545) 1
(P248)
(P698) 15829326
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/15829326

Roy M Bremnes
(P1545) 2
(P248)
(P698) 15829326
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/15829326

Ulf Aasebø
(P1545) 4
(P248)
(P698) 15829326
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/15829326

Steinar Aamdal
(P1545) 5
(P248)
(P698) 15829326
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/15829326

Norwegian Lung Cancer Study Group
(P1545) 6
(P248)
(P698) 15829326
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/15829326

other details
description scientific article published on 15 December 2004

External Links
(P356) 10.1016/J.LUNGCAN.2004.10.016
(P698) 15829326